Intelligent Bio Solutions (INBS) EBITDA Margin (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly EBITDA Margin of 334.03% in Q1 2025, up 15.45% quarter-over-quarter from 395.06% in Q4 2024, and up 4601.0% on a YoY basis from 7.11% in Q1 2024.
Intelligent Bio Solutions (INBS) EBITDA Margin (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' EBITDA Margin history runs 7 years deep, the most recent figure standing at 334.03% for Q1 2025.
- In Q1 2025, EBITDA Margin rose 4601.0% year-over-year to 334.03%; the TTM figure through Mar 2025 stood at 333.88% (up 2275.0% YoY), while the FY2023 annual figure was 831.58%, down 29068.0% from the prior year.
- EBITDA Margin was 334.03% for Q1 2025 at Intelligent Bio Solutions, up from 395.06% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 16.54% in Q4 2022 to a low of 9929.13% in Q1 2021.
- Historically, EBITDA Margin has averaged 1153.12% across 5 years, with a median of 380.04% in 2024.
- The sharpest annual moves came in 2021 and 2022: EBITDA Margin sank 804890 bps in 2021, then surged 923695 bps in 2022.
- A 5-year view of EBITDA Margin shows it stood at 1941.97% in 2021, then soared by 99 bps to 16.54% in 2022, then plunged by 1404 bps to 248.83% in 2023, then plunged by 59 bps to 395.06% in 2024, then climbed by 15 bps to 334.03% in 2025.
- The last three EBITDA Margin figures came in at 334.03% (Q1 2025), 395.06% (Q4 2024), and 284.13% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -334.03% |
| Dec 31, 2024 | -395.06% |
| Sep 30, 2024 | -284.13% |
| Mar 31, 2024 | -380.04% |
| Dec 31, 2023 | -248.83% |
| Sep 30, 2023 | -306.90% |
| Jun 30, 2023 | -588.31% |
| Mar 31, 2023 | -1,405.01% |
| Dec 31, 2022 | -16.54% |
| Sep 30, 2022 | -388.40% |
| Jun 30, 2022 | -180.72% |
| Mar 31, 2022 | -692.18% |
| Dec 31, 2021 | -1,941.97% |
| Jun 30, 2021 | -205.49% |
| Mar 31, 2021 | -9,929.13% |
| Dec 31, 2020 | -688.99% |
| Sep 30, 2020 | -2,026.23% |
| Jun 30, 2020 | 4,405.44% |
| Mar 31, 2020 | -1,880.23% |
| Dec 31, 2019 | -213,523.18% |